Search Clinical Trials

589,087 trials

NCT07643987
Completed
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health System
NCT07645508
Active Not Recruiting
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation in Reverse Total Shoulder ArthroplastyKrankenhaus Barmherzige Schwestern Linz
NCT07644689
CompletedNot Applicable
Triple-Scan Protocol to Assess PassivityMansoura University
NCT07644351
Completed
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis Pharmaceuticals
NCT07643870
Not Yet RecruitingPhase 1
Human ADME Study of [14C]-AZD1390AstraZeneca
NCT07646574
Not Yet Recruiting
Non-surgical Management After NIT for dMMR/MSI-H GCYong Zhou
NCT07645157
RecruitingPhase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical University
NCT07645638
CompletedNot Applicable
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de Burgos
NCT07645339
Active Not RecruitingNot Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'Oreal
NCT07643766
Not Yet RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisEnveda Therapeutics
NCT07646535
Not Yet RecruitingPhase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.
NCT07645495
Not Yet RecruitingNot Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
NCT07645105
Completed
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of Silesia
NCT07645820
Recruiting
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis FlaresCastle Biosciences Incorporated
NCT07645118
Not Yet RecruitingPhase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07644143
Not Yet RecruitingNot Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07644442
CompletedPhase 1
Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male SubjectsHutchmed
NCT07645846
Not Yet RecruitingPhase 2
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital, Sun Yat-Sen University